Positron emission tomography imaging of T-cell activity in cardiovascular disease and its emerging role in imaging adaptive immunity
American Journal of Nuclear Medicine and Molecular Imaging · 2026 · 16 (2) · 77-89
DOI: 10.62347/hdti2868 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Nuclear Medicine and Molecular Imaging, 2026. Verfasst von Albab S Uddin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology and Imaging Sciences, Indiana University School of Medicine Indianapolis, IN, USA. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
F]F-AraG have entered early clinical trials, demonstrating feasibility and safety in humans. Other tracers, including CD4- and CD3-directed antibodies, IL-2R and OX40 probes, checkpoint tracers (PD-1, CTLA-4), and granzyme B ligands, remain largely preclinical but show strong potential for cardiovascular translation. Applications span acute myocarditis, noninvasive transplant rejection surveillance, assessment of post-MI immune remodeling, plaque vulnerability in atherosclerosis, and systemic immune activation in long COVID. Compared with existing imaging modalities, T-cell PET offers cell-type specificity, quantitative longitudinal monitoring, and the capacity for whole-body immune mapping, particularly when integrated with total-body PET or hybrid PET/MR. Challenges include low T-cell density in the myocardium, tracer specificity, radiation burden, and the need for histopathologic validation. Future directions involve repurposing oncology tracers for cardiology, engineering antibody fragments with improved kinetics, and establishing T-cell PET as a mechanistic biomarker in cardiovascular clinical trials. With further innovation and validation, T-cell PET has the potential to evolve from an experimental tool into a clinically actionable modality, reshaping the management of immune-mediated heart disease.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology and Imaging Sciences, Indiana University School of Medicine Indianapolis, IN, USA.
- Department of Radiation Oncology, Indiana University School of Medicine Indianapolis, IN, USA.
- Advanced Molecular Imaging Research Laboratory, Purdue University West Lafayette, IN, USA.
Zitieren
APA
Uddin, A. S., Bulusu, S., Oderinde, O. M., & Zheng, Q. H. (2026). Positron emission tomography imaging of T-cell activity in cardiovascular disease and its emerging role in imaging adaptive immunity. American Journal of Nuclear Medicine and Molecular Imaging, 16(2), 77-89. https://doi.org/10.62347/hdti2868
Vancouver
Uddin AS, Bulusu S, Oderinde OM, Zheng QH. Positron emission tomography imaging of T-cell activity in cardiovascular disease and its emerging role in imaging adaptive immunity. American Journal of Nuclear Medicine and Molecular Imaging. 2026;16(2):77-89. doi:10.62347/hdti2868
BibTeX
@article{Uddin2026,
author = {Uddin, Albab S and Bulusu, Shreyas and Oderinde, Oluwaseyi M and Zheng, Qi-Huang},
title = {Positron emission tomography imaging of T-cell activity in cardiovascular disease and its emerging role in imaging adaptive immunity},
journal = {American Journal of Nuclear Medicine and Molecular Imaging},
year = {2026},
volume = {16},
number = {2},
pages = {77--89},
doi = {10.62347/hdti2868}
}
EUVIMED